The roles of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine

Yakugaku Zasshi

Volumn 126, Issue 2, 2006, Pages 117-121

  Gültekin, Hülya ^a   Ahmedov, Vefadar ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Analgesia; L NOARG; Naloxone; Venlafaxine

Indexed keywords

N(G) NITROARGININE; NALOXONE; NITRIC OXIDE; OPIATE RECEPTOR; VENLAFAXINE; ANALGESIC AGENT; CYCLOHEXANOL DERIVATIVE; ENZYME INHIBITOR; NARCOTIC ANTAGONIST; NITRIC OXIDE SYNTHASE; SEROTONIN UPTAKE INHIBITOR;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; FEMALE; HIGH TEMPERATURE; HINDLIMB; HOT PLATE TEST; LICKING; LOW DRUG DOSE; MALE; MEDICAL ASSESSMENT; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; RAT; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; WISTAR RAT;

ANALGESICS; ANIMALS; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SEROTONIN UPTAKE INHIBITORS;

EID: 31644441942     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.117     Document Type: Article

References (21)

1. Dwight M. M., Arnold L. M., O'Brien H., Metzger R., Morris-Park E., Keck Jr. P. E., Psychosomatics, 39, 14-17 (1998).
2. Grothe D. R., Scheckner B., Albano D., Pharmacotherapy, 24, 621-629 (2004).
3. Ozyalcin S. N., Talu G. K., Kiziltan E., Yucel B., Ertas M., Disci R., Headache, 45, 144-152 (2005).
4. Bulut S., Berilgen M. S., Baran A., Tekatas A., Atmaca M., Mungen B., Clin. Neurol. Neurosurg., 107, 44-48 (2004).
5. Schreiber S., Bleich A., Pick C.G., J. Mol. Neurosci., 18, 143-149 (2002).
6. Schreiber S., Backer M. M., Pick C. G., Neurosci. Lett., 273, 85-88 (1999).
7. Marchand F., Alloui A., Chapuy E., Hernandez A., Pelissier T., Ardid D., Eschalier A., Neurosci. Lett., 342, 105-108 (2003).
8. Marchand F., Alloui A., Chapuy E., Jourdan D., Pelissier T., Ardid D., Hernandez A., Eschalier A., Pain, 103, 229-235 (2003).
9. Berrocoso E., Rojas-Corrales M. O., Mico J. A., Neurosci. Lett., 363, 25-28 (2004).
10. Cizkova D., Lukacova N., Marsala M., Marsala J., Brain Res. Bull., 58, 161-171 (2002).
11. Ferreira J., Santos R. S., Calixto J. B., Neuropharmacology, 38, 835-842 (1999).
12. Sousa A., Prado W. A., Brain Res., 897, 9-19 (2001).
13. Sindrup S. H., Otto M., Finnerup N. B., Jensen T. S., Basic Clin. Pharmacol. Toxicol., 96, 399-409 (2005).
14. Mattia C., Paoletti F., Coluzzi F., Boanelli A., Minerva Anestesiol., 68, 105-114 (2002).
15. Grevert P., Goldstein A., Psychopharmacology (Berl), 18, 111-113 (1977).
16. Jayaram A., Singh P., Carp H. M., Anesthesiology, 82, 1283-1287 (1995).
17. Sawynok J., Reid A. R., Doak G. J., Pain, 61, 203-213 (1995).
18. Millan M. J., Prog. Neurobiol., 57, 1-164 (1999).
19. Salter M., Strjbos P. J., Neale S., Duffy C., Follenfant R. L., Gartwaite, J., Neuroscience, 73, 649-655 (1996).
20. Lam H. H. D., Hanley D. F., Trapp B. D., Saito S., Raja S., Dawson T. M., Yamaguchi H., Neurosci. Lett., 210, 201-204 (1996).
21. Beirith A., Adair R., Santos S., Calixto J., Brain Res., 924, 219-228 (2002).